http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2387997-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 |
filingDate | 2010-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-2387997-A1 |
titleOfInvention | Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients who developed permanent atrial fibrillation throughout the period the dronedarone is administered |
abstract | Use of dronedarone or a pharmaceutically acceptable salt thereof for the preparation of a medicament for the prevention of cardiovascular events notably stroke, acute coronary syndrome or cardiovascular death in patients who developed permanent atrial fibrillation/flutter throughout the period the dronedarone or a pharmaceutically acceptable salt thereof is administered. |
priorityDate | 2010-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.